169 related articles for article (PubMed ID: 28470096)
1. Epigenetics in endometrial carcinogenesis - part 1: DNA methylation.
Bartosch C; Lopes JM; Jerónimo C
Epigenomics; 2017 May; 9(5):737-755. PubMed ID: 28470096
[TBL] [Abstract][Full Text] [Related]
2. Epigenetics in endometrial carcinogenesis - part 2: histone modifications, chromatin remodeling and noncoding RNAs.
Bartosch C; Lopes JM; Jerónimo C
Epigenomics; 2017 Jun; 9(6):873-892. PubMed ID: 28523964
[TBL] [Abstract][Full Text] [Related]
3. Current concepts in the pathology and epigenetics of endometrial carcinoma.
Arafa M; Somja J; Dehan P; Kridelka F; Goffin F; Boniver J; Delvenne P
Pathology; 2010 Dec; 42(7):613-7. PubMed ID: 21080868
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation in endometrial cancer.
Tao MH; Freudenheim JL
Epigenetics; 2010 Aug; 5(6):491-8. PubMed ID: 20543579
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide DNA methylation profile of early-onset endometrial cancer: its correlation with genetic aberrations and comparison with late-onset endometrial cancer.
Makabe T; Arai E; Hirano T; Ito N; Fukamachi Y; Takahashi Y; Hirasawa A; Yamagami W; Susumu N; Aoki D; Kanai Y
Carcinogenesis; 2019 Jul; 40(5):611-623. PubMed ID: 30850842
[TBL] [Abstract][Full Text] [Related]
6. Carcinogenic mechanisms of endometrial cancer: involvement of genetics and epigenetics.
Banno K; Yanokura M; Iida M; Masuda K; Aoki D
J Obstet Gynaecol Res; 2014 Aug; 40(8):1957-67. PubMed ID: 25131761
[TBL] [Abstract][Full Text] [Related]
7. Research Progress of DNA Methylation in Endometrial Cancer.
Xu T; Ding H; Chen J; Lei J; Zhao M; Ji B; Chen Y; Qin S; Gao Q
Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883495
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic mechanisms in endometrial cancer.
Stampoliou A; Arapantoni-Dadioti P; Pavlakis K
J BUON; 2016; 21(2):301-6. PubMed ID: 27273937
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation as mechanism of apoptotic resistance development in endometrial cancer patients.
Fialkova V; Vidomanova E; Balharek T; Marcinek J; Kudela E; Hanysova S; Visnovsky J; Dobrota D; Hatok J
Gen Physiol Biophys; 2017 Dec; 36(5):521-529. PubMed ID: 29372685
[TBL] [Abstract][Full Text] [Related]
10. DNA Methylation Machinery in the Endometrium and Endometrial Cancer.
Caplakova V; Babusikova E; Blahovcova E; Balharek T; Zelieskova M; Hatok J
Anticancer Res; 2016 Sep; 36(9):4407-20. PubMed ID: 27630276
[TBL] [Abstract][Full Text] [Related]
11. Significance of PTEN alterations in endometrial carcinoma: a population-based study of mutations, promoter methylation and PTEN protein expression.
Salvesen HB; Stefansson I; Kretzschmar EI; Gruber P; MacDonald ND; Ryan A; Jacobs IJ; Akslen LA; Das S
Int J Oncol; 2004 Dec; 25(6):1615-23. PubMed ID: 15547698
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic DNA hypermethylation: clinical applications in endometrial cancer (Review).
Muraki Y; Banno K; Yanokura M; Kobayashi Y; Kawaguchi M; Nomura H; Hirasawa A; Susumu N; Aoki D
Oncol Rep; 2009 Nov; 22(5):967-72. PubMed ID: 19787208
[TBL] [Abstract][Full Text] [Related]
13. Quantitative DNA methylation analysis of selected genes in endometrial carcinogenesis.
Chen YC; Tsao CM; Kuo CC; Yu MH; Lin YW; Yang CY; Li HJ; Yan MD; Wang TJ; Chou YC; Su HY
Taiwan J Obstet Gynecol; 2015 Oct; 54(5):572-9. PubMed ID: 26522113
[TBL] [Abstract][Full Text] [Related]
14. Importance of promoter methylation of GATA4 and TP53 genes in endometrioid carcinoma of endometrium.
Chmelarova M; Kos S; Dvorakova E; Spacek J; Laco J; Ruszova E; Hrochova K; Palicka V
Clin Chem Lab Med; 2014 Aug; 52(8):1229-34. PubMed ID: 24651021
[TBL] [Abstract][Full Text] [Related]
15. Methylation analysis of tumor suppressor genes in endometroid carcinoma of endometrium using MS-MLPA.
Dvorakova E; Chmelarova M; Laco J; Palicka V; Spacek J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Dec; 157(4):298-303. PubMed ID: 23736679
[TBL] [Abstract][Full Text] [Related]
16. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylation in promoter region of E-cadherin gene is associated with tumor dedifferention and myometrial invasion in endometrial carcinoma.
Saito T; Nishimura M; Yamasaki H; Kudo R
Cancer; 2003 Feb; 97(4):1002-9. PubMed ID: 12569599
[TBL] [Abstract][Full Text] [Related]
18. Application of DNA methylation biomarkers for endometrial cancer management.
Jiang SW; Li J; Podratz K; Dowdy S
Expert Rev Mol Diagn; 2008 Sep; 8(5):607-16. PubMed ID: 18785809
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic changes as prognostic predictors in endometrial carcinomas.
Farkas SA; Sorbe BG; Nilsson TK
Epigenetics; 2017 Jan; 12(1):19-26. PubMed ID: 27874289
[TBL] [Abstract][Full Text] [Related]
20. Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma.
Velasco A; Pallares J; Santacana M; Gatius S; Fernandez M; Domingo M; Valls J; Yeramian A; Encinas M; Dolcet X; Matias-Guiu X
Hum Pathol; 2011 Feb; 42(2):185-93. PubMed ID: 21111454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
